BioCopy AG presents ValidaTe, a novel ultra-fast screening t

BioCopy AG presents ValidaTe, a novel ultra-fast screening technology to significantly speed up drug discovery in T-cell therapy

ValidaTe enables characterization of efficacy and safety of T-cell drug candidates in days rather than months The breakthrough speed and unprecedented density of data processed can give partner

Related Keywords

Germany , Allschwil , Switzerland General , Switzerland , Kostenloser Wertpapierhandel , Claudia Dupp , , Biocopy , Presents , Validate , Novel , Ultra , Mast , Screening , Technology , Ignificantly , Speed , Drug , Discovery , Fell , Therapy ,